Attention Control Training (ACT) and Very Preterm Infants

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 11, 2018

Primary Completion Date

June 28, 2019

Study Completion Date

March 11, 2020

Conditions
Very Premature Baby
Interventions
BEHAVIORAL

Attention Control Training

Infants watch interactive cartoons that respond to infants' direction of gaze. An eye-tracker records the infant's eye movements in real time, relaying this information to the computer. These presentations trigger motivating stimuli (cartoon animations with child-friendly sounds) every time the infant fulfills the demands of a task (e.g. when the infant looks at a character on the screen avoiding to be distracted by other objects moving across the screen). The length of training sessions varies depending on infants' engagement with stimuli and time criteria.

BEHAVIORAL

Control

The control procedure involves presentation of cartoons on a screen, while infants' gaze direction is recorded using the same eye-tracker and camera. The crucial difference is that the cartoons in this case are not interactive, thus do not change depending on infants' gaze direction. To ensure presentations in the control procedure are similar in length to those of the intervention group, infants in the control group are matched infant-by-infant and visit-by-visit with participants in the ACT treatment group: Infants in the control group see a replay of the session of the matched treated infant. Therefore, while the presentation is exactly the same (i.e. same length and same stimuli) for the treated and the control child, in the latter case the presentation is not interactive (i.e. not generated contingently on the infants' visual behaviour).

Trial Locations (1)

BT9 7BL

Queen's University Belfast, Belfast

All Listed Sponsors
collaborator

Public Health Agency, Health and Social Care Research and Development

OTHER

collaborator

TinyLife

OTHER

lead

Queen's University, Belfast

OTHER

NCT03896490 - Attention Control Training (ACT) and Very Preterm Infants | Biotech Hunter | Biotech Hunter